JPS53101515A - Medicine having anodyne * sedative and antiallergic activity and production thereof - Google Patents
Medicine having anodyne * sedative and antiallergic activity and production thereofInfo
- Publication number
- JPS53101515A JPS53101515A JP1649877A JP1649877A JPS53101515A JP S53101515 A JPS53101515 A JP S53101515A JP 1649877 A JP1649877 A JP 1649877A JP 1649877 A JP1649877 A JP 1649877A JP S53101515 A JPS53101515 A JP S53101515A
- Authority
- JP
- Japan
- Prior art keywords
- anodyne
- sedative
- medicine
- production
- antiallergic activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1649877A JPS53101515A (en) | 1977-02-17 | 1977-02-17 | Medicine having anodyne * sedative and antiallergic activity and production thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1649877A JPS53101515A (en) | 1977-02-17 | 1977-02-17 | Medicine having anodyne * sedative and antiallergic activity and production thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS53101515A true JPS53101515A (en) | 1978-09-05 |
JPS6339572B2 JPS6339572B2 (en) | 1988-08-05 |
Family
ID=11917938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1649877A Granted JPS53101515A (en) | 1977-02-17 | 1977-02-17 | Medicine having anodyne * sedative and antiallergic activity and production thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS53101515A (en) |
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5835117A (en) * | 1981-08-25 | 1983-03-01 | Nippon Zoki Pharmaceut Co Ltd | Novel physiologically active substance, nsh |
JPS59118711A (en) * | 1982-12-25 | 1984-07-09 | Nippon Zoki Pharmaceut Co Ltd | Novel physiologically active substance |
US5013558A (en) * | 1988-06-20 | 1991-05-07 | Nippon Zoki Pharmaceutical Co., Ltd. | Pharmaceutical treatments for cerebral and neuronal diseases |
US5057324A (en) * | 1987-07-23 | 1991-10-15 | Nippon Zoki Pharmaceutical Co., Ltd. | Kallikrein inhibitor substance, a process for preparation and pharmaceutical compositions thereof |
US5534509A (en) * | 1993-03-19 | 1996-07-09 | Nippon Zoki Pharmaceutical Co., Ltd. | Pharmaceutical composition regulating function of a living body |
US5560935A (en) * | 1993-09-28 | 1996-10-01 | Nippon Zoki Pharmaceutical Co., Ltd. | Physiologically active substances extracted from activated tissues |
US5599683A (en) * | 1993-08-06 | 1997-02-04 | Nippon Zoki Pharmaceutical Co., Ltd. | Method for measuring production activity of test substance towards FXIIa |
US5648228A (en) * | 1993-08-06 | 1997-07-15 | Nippon Zoki Pharmaceutical Co., Ltd. | Measuring activity toward production of activated blood coagulation factor XII, plasma kallikrein or bradykinin using reconstituted kallikrein-kinin system |
EP0852950A1 (en) * | 1997-01-08 | 1998-07-15 | Nippon Zoki Pharmaceutical Co., Ltd. | Nitrogen monoxide production suppressor |
US6165515A (en) * | 1997-09-12 | 2000-12-26 | Nippon Zoki Pharmaceutical Co., Ltd. | Method for treatment of osteoporosis |
US6365192B1 (en) | 1999-04-15 | 2002-04-02 | Nippon Zoki Pharmaceutical Co., Ltd. | Bioactivating substance |
US6541041B1 (en) | 1997-11-28 | 2003-04-01 | Nippon Zoki Pharmaceutical Co., Ltd. | Crude drug extracts, and methods for making and standardizing same |
US6726932B2 (en) | 2000-02-18 | 2004-04-27 | Nippon Zoki Pharmaceutical Co., Ltd. | Fatty acid-containing composition |
WO2004039383A1 (en) * | 2002-10-31 | 2004-05-13 | Nippon Zoki Pharmaceutical Co., Ltd. | Remedy for fibromyalgia |
US6913900B2 (en) | 2001-08-29 | 2005-07-05 | Nippon Zoki Pharmaceutical Co., Ltd. | Plasma prekallikrein activation and kallikrein production assay |
WO2007114230A1 (en) | 2006-03-30 | 2007-10-11 | Kyoto University | Thioredoxin production promoting agent |
WO2009028605A1 (en) | 2007-08-31 | 2009-03-05 | Kyushu University, National University Corporation | Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent |
WO2011111770A1 (en) | 2010-03-11 | 2011-09-15 | 日本臓器製薬株式会社 | Ameliorating or therapeutic agent for chronic prostatitis, interstitial cystitis and/or urination disorders |
WO2011162317A1 (en) | 2010-06-25 | 2011-12-29 | 日本臓器製薬株式会社 | Method for determination or evaluation of substance of interest |
US8293280B2 (en) | 2004-12-17 | 2012-10-23 | Nippon Zoki Pharmaceutical Co., Ltd. | Method for treatment of HIV infection |
US8568789B2 (en) | 2004-12-01 | 2013-10-29 | Nippon Zoki Pharmaceutical Co., Ltd. | Dried product and a process for manufacturing the product |
WO2013173941A1 (en) * | 2012-05-25 | 2013-11-28 | Well Resources Limited | Peptide and the use thereof |
JP2014209129A (en) * | 2006-09-06 | 2014-11-06 | 日本臓器製薬株式会社 | Evaluation method of substance to be inspected |
WO2017146230A1 (en) * | 2016-02-24 | 2017-08-31 | 国立大学法人大阪大学 | Test method |
US9884077B2 (en) | 2013-04-30 | 2018-02-06 | Nippon Zoki Pharmaceutical Co., Ltd. | Extract and preparation containing said extract |
JP2018048129A (en) * | 2016-09-14 | 2018-03-29 | 日本臓器製薬株式会社 | Agent for improving or treating erythromelalgia |
US10711292B2 (en) | 2010-10-14 | 2020-07-14 | Nikkon Zoki Pharmaceutical Co., Ltd. | Method for promoting the synthesis of collagen and proteoglycan in chondrocytes |
US11207354B2 (en) | 2016-09-23 | 2021-12-28 | Osaka University | Schwann cell differentiation promoting agent and a peripheral nerve regeneration promoting agent |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1207005C (en) | 2002-10-31 | 2005-06-22 | 威世药业(如皋)有限公司 | Rabbit skin containing bioactive substance and its use |
-
1977
- 1977-02-17 JP JP1649877A patent/JPS53101515A/en active Granted
Cited By (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5835117A (en) * | 1981-08-25 | 1983-03-01 | Nippon Zoki Pharmaceut Co Ltd | Novel physiologically active substance, nsh |
JPH0343279B2 (en) * | 1981-08-25 | 1991-07-01 | Nippon Zoki Pharmaceutical Co | |
JPS59118711A (en) * | 1982-12-25 | 1984-07-09 | Nippon Zoki Pharmaceut Co Ltd | Novel physiologically active substance |
JPH0330598B2 (en) * | 1982-12-25 | 1991-04-30 | ||
US5057324A (en) * | 1987-07-23 | 1991-10-15 | Nippon Zoki Pharmaceutical Co., Ltd. | Kallikrein inhibitor substance, a process for preparation and pharmaceutical compositions thereof |
US5013558A (en) * | 1988-06-20 | 1991-05-07 | Nippon Zoki Pharmaceutical Co., Ltd. | Pharmaceutical treatments for cerebral and neuronal diseases |
US5658896A (en) * | 1993-03-19 | 1997-08-19 | Nippon Zoki Pharmaceutical Co., Ltd. | Pharmaceutical composition regulating function of a living body |
US5534509A (en) * | 1993-03-19 | 1996-07-09 | Nippon Zoki Pharmaceutical Co., Ltd. | Pharmaceutical composition regulating function of a living body |
US5807951A (en) * | 1993-03-19 | 1998-09-15 | Nippon Zoki Pharmaceutical Co., Ltd. | Pharmaceutical composition regulating function of a living body |
US5599683A (en) * | 1993-08-06 | 1997-02-04 | Nippon Zoki Pharmaceutical Co., Ltd. | Method for measuring production activity of test substance towards FXIIa |
US5648228A (en) * | 1993-08-06 | 1997-07-15 | Nippon Zoki Pharmaceutical Co., Ltd. | Measuring activity toward production of activated blood coagulation factor XII, plasma kallikrein or bradykinin using reconstituted kallikrein-kinin system |
US5560935A (en) * | 1993-09-28 | 1996-10-01 | Nippon Zoki Pharmaceutical Co., Ltd. | Physiologically active substances extracted from activated tissues |
EP0852950A1 (en) * | 1997-01-08 | 1998-07-15 | Nippon Zoki Pharmaceutical Co., Ltd. | Nitrogen monoxide production suppressor |
US6051613A (en) * | 1997-01-08 | 2000-04-18 | Nippon Zoki Pharmaceutical Co., Ltd. | Nitrogen monoxide production suppressor |
US6165515A (en) * | 1997-09-12 | 2000-12-26 | Nippon Zoki Pharmaceutical Co., Ltd. | Method for treatment of osteoporosis |
US6541041B1 (en) | 1997-11-28 | 2003-04-01 | Nippon Zoki Pharmaceutical Co., Ltd. | Crude drug extracts, and methods for making and standardizing same |
US6576241B2 (en) | 1997-11-28 | 2003-06-10 | Nippon Zoki Pharmaceutical Co., Ltd. | Crude drug extracts, and methods for making and standardizing same |
US6365192B1 (en) | 1999-04-15 | 2002-04-02 | Nippon Zoki Pharmaceutical Co., Ltd. | Bioactivating substance |
US6726932B2 (en) | 2000-02-18 | 2004-04-27 | Nippon Zoki Pharmaceutical Co., Ltd. | Fatty acid-containing composition |
US6913900B2 (en) | 2001-08-29 | 2005-07-05 | Nippon Zoki Pharmaceutical Co., Ltd. | Plasma prekallikrein activation and kallikrein production assay |
US7435547B2 (en) | 2002-10-31 | 2008-10-14 | Nippon Zoki Pharmaceutical Co., Ltd. | Therapeutic agent for fibromyalgia |
US7238487B2 (en) | 2002-10-31 | 2007-07-03 | Nippon Zoki Pharmaceutical Co., Ltd. | Therapeutic agent for fibromyalgia |
WO2004039383A1 (en) * | 2002-10-31 | 2004-05-13 | Nippon Zoki Pharmaceutical Co., Ltd. | Remedy for fibromyalgia |
AU2003280684B2 (en) * | 2002-10-31 | 2009-06-25 | Nippon Zoki Pharmaceutical Co., Ltd. | Remedy for fibromyalgia |
US7148012B2 (en) | 2002-10-31 | 2006-12-12 | Nippon Zoki Pharmaceutical Co., Ltd. | Therapeutic agent for fibromyalgia |
US8568789B2 (en) | 2004-12-01 | 2013-10-29 | Nippon Zoki Pharmaceutical Co., Ltd. | Dried product and a process for manufacturing the product |
US8293280B2 (en) | 2004-12-17 | 2012-10-23 | Nippon Zoki Pharmaceutical Co., Ltd. | Method for treatment of HIV infection |
WO2007114230A1 (en) | 2006-03-30 | 2007-10-11 | Kyoto University | Thioredoxin production promoting agent |
US8338108B2 (en) | 2006-03-30 | 2012-12-25 | Kyoto University | Agent for promoting the production of thioredoxin |
JP2014209129A (en) * | 2006-09-06 | 2014-11-06 | 日本臓器製薬株式会社 | Evaluation method of substance to be inspected |
WO2009028605A1 (en) | 2007-08-31 | 2009-03-05 | Kyushu University, National University Corporation | Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent |
US8613962B2 (en) | 2007-08-31 | 2013-12-24 | Kyushu University, National University Corporation | Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent |
WO2011111770A1 (en) | 2010-03-11 | 2011-09-15 | 日本臓器製薬株式会社 | Ameliorating or therapeutic agent for chronic prostatitis, interstitial cystitis and/or urination disorders |
CN102791277B (en) * | 2010-03-11 | 2016-05-04 | 日本脏器制药株式会社 | The improvement of chronic prostatitis, interstitial cystitis and/or urination disorder or therapeutic agent |
CN102791277A (en) * | 2010-03-11 | 2012-11-21 | 日本脏器制药株式会社 | Ameliorating or therapeutic agent for chronic prostatitis, interstitial cystitis and/or urination disorders |
US9011849B2 (en) | 2010-03-11 | 2015-04-21 | Nippon Zoki Pharmaceutical Co., Ltd. | Ameliorating or therapeutic agent for chronic prostatitis, interstitial cystitis and/or urination disorders |
US9447466B2 (en) | 2010-06-25 | 2016-09-20 | Nippon Zoki Pharmaceutical Co., Ltd. | Method for determination or evaluation of test substance |
WO2011162317A1 (en) | 2010-06-25 | 2011-12-29 | 日本臓器製薬株式会社 | Method for determination or evaluation of substance of interest |
US10711292B2 (en) | 2010-10-14 | 2020-07-14 | Nikkon Zoki Pharmaceutical Co., Ltd. | Method for promoting the synthesis of collagen and proteoglycan in chondrocytes |
WO2013173941A1 (en) * | 2012-05-25 | 2013-11-28 | Well Resources Limited | Peptide and the use thereof |
US9422336B2 (en) | 2012-05-25 | 2016-08-23 | Well Resources Limited | Peptide for treatment of disease or symptoms associated with pain |
US9839666B2 (en) | 2012-05-25 | 2017-12-12 | Wells Resources Limited | Peptide and a use thereof |
US9884077B2 (en) | 2013-04-30 | 2018-02-06 | Nippon Zoki Pharmaceutical Co., Ltd. | Extract and preparation containing said extract |
WO2017146230A1 (en) * | 2016-02-24 | 2017-08-31 | 国立大学法人大阪大学 | Test method |
JPWO2017146230A1 (en) * | 2016-02-24 | 2019-02-14 | 国立大学法人大阪大学 | Test method |
US11129976B2 (en) | 2016-02-24 | 2021-09-28 | Osaka University | Test method |
JP2018048129A (en) * | 2016-09-14 | 2018-03-29 | 日本臓器製薬株式会社 | Agent for improving or treating erythromelalgia |
US11207354B2 (en) | 2016-09-23 | 2021-12-28 | Osaka University | Schwann cell differentiation promoting agent and a peripheral nerve regeneration promoting agent |
Also Published As
Publication number | Publication date |
---|---|
JPS6339572B2 (en) | 1988-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS53101515A (en) | Medicine having anodyne * sedative and antiallergic activity and production thereof | |
PH16364A (en) | 1-(3-amino-2-hydroxypropyl)-2-nitroimidazole derivatives and pharmaceutical preparation | |
JPS5463047A (en) | Novel acylanilide*its manufacture and pharmaceutical or veternary composition having antiandrogen activity | |
JPS5555113A (en) | Oral administration medical tablet and its manufacture | |
DE2862017D1 (en) | Xanthine derivatives having antiallergic activity and pharmacological preparations containing them | |
GB2073589B (en) | Diagnostic and therapeutic radio pharmaceutical capsules | |
JPS5636481A (en) | Aminopiperidine* its manufacture* intermediate and medicine | |
JPS5618982A (en) | Pyrimidine derivatives and medicinal drug containing them | |
GB2006774B (en) | Deoxy-narasin antibioticx their production and use | |
JPS568382A (en) | 22substituted quinuclidine derivative and medicine therefrom | |
ZA784683B (en) | Pseudotrisaccharides,their production and their medicinal use | |
GB2103927B (en) | Sub-dermal drug implants and their production | |
JPS53145905A (en) | Pharmaceutical composition and production thereof | |
GB2075342B (en) | Sedative drug | |
JPS5490172A (en) | Substituted 11phenyll22pyrrolidinii22yll ethanol*its manufacture and drug having analgesic activity*containing it | |
JPS56131509A (en) | Agricultural drug and manufacture | |
JPS5470255A (en) | Nnbenzylanthracycline and pharmaceutical composition | |
JPS53104736A (en) | Drug having pharmacological and 1 or antiibacterial activity | |
GB2048250B (en) | 2-amino-6-aryl-4-pyrimidinols and their pharmaceutical uses | |
JPS5726682A (en) | Substituted 2-cyclopropyl-chromone, manufacture and antiallergic pharmaceutical composition | |
JPS5444659A (en) | Novel medicine based on 22benzylidenee33 benzofuranon*novel 22benzylidinee33benzofuranon and their manufacture | |
JPS54109999A (en) | Novel purine derivative*its manufacture and drug containing it and having antiallergic* antiiinflammatory and antiedematous activity | |
ZA796294B (en) | Pharmaceutical compositions with central depressant and antipsychotic activity | |
JPS53101095A (en) | Quickkcrystallizing polyethyleneterephthalates and their manufacture | |
ZA784842B (en) | New 3,4,5-trihydroxypiperidine compounds,their production and their medicinal use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term |